Avoiding COBRA Notice Litigation: Ensuring Compliance and Reducing Risk for Companies

Not many general counsels will declare that their company’s COBRA notice is what keeps them awake at night. Yet, as recent class action litigation reveals, challenges to COBRA notices and issues that present themselves can be simply addressed to evade complex litigation. Consolidated Omnibus Budget Reconciliation Act (COBRA) provides employees and their families who lose…

Read More

District of Massachusetts Adopts But-For Causation Standard in FCA Cases Based on AKS Infringements

On September 27, 2023, a monumental decision emerged from the District of Massachusetts. The Chief Judge ruled that in False Claims Act (“FCA”) cases rooted in alleged infringements of the Anti-Kickback Statute (“AKS”), the applicable standard is but-for causation. This decision diverges from the regular citation of the 2018 Third Circuit case, United States ex…

Read More

Arizona Court Ruling Sheds Light on Statutory Limitations in Public Records Access: National Implications for Legal Professionals

In a decision that could impact many legal professionals, the Arizona Court of Appeals issued a pertinent opinion in Audit-USA v. Maricopa County in February of 2023. The case offers significant insight into the complexities of Arizona’s public records laws. The court’s decision provides a noteworthy reminder of the practices mandated by statute, which may…

Read More

Fourth Circuit Clarifies Unjust Enrichment Standards under ERISA’s Equitable Relief Provision

The United States Court of Appeals for the Fourth Circuit has recently established new standards for plaintiffs seeking unjust enrichment as an equitable remedy under the Employee Retirement Income Security Act (ERISA). This development offers clarity about the circumstances under which a plaintiff may seek a monetary recovery under § 502(a)(3) of ERISA, a section…

Read More

FDA Issues New Draft Guidance on Biosimilar Labeling: Impact on Legal Professionals and Regulatory Compliance

In an unprecedented move, the Food and Drug Administration (FDA) issued a new draft guidance on September 18, 2023, named “Labeling for Biosimilar and Interchangeable Biosimilar Products”. It replaces their previous labeling guidance “Labeling for Biosimilar Products” from July 2018. Detailed by Venable LLP, the FDA specified significant revisons from the prior guidance. The agency…

Read More

Bankman-Fried’s Legal Battle Sheds Light on Fraud, D&O Insurance, and Litigation Strategies

Amidst the unfolding drama of Sam Bankman-Fried’s legal battles, the case reveals substantial lessons on fraud, directors’ and officers’ (D&O) insurance, and the decision-making processes involved during criminal trials. Bankman-Fried’s criminal trial kicked off recently, which in itself would normally be a headline-grabber. However, on the same day, he also levied a lawsuit against one…

Read More

Diverging Court Decisions Create Uncertainty in False Claims Act Litigation Landscape

False Claims Act (FCA) litigation has been a legal stumbling block widely observed in U.S. courts, particularly regarding cases allegedly founded on kickback systems. Differing interpretations of the applicable causation standards have created a jurisprudential rift, marked by continued struggle among various courts around the nation. At present, the U.S. Supreme Court has chosen to…

Read More

Examining the Current Controversies Surrounding the US Supreme Court

Welcome to this week’s roundup of legal highlights from Howard Bashman’s How Appealing blog, a service dedicated to providing updates on appellate litigation. This week’s collection includes insights and commentary on a range of topics, with emphasis on the controversies surrounding the U.S. Supreme Court. In a recent Jurisprudence essay published on Slate, Sarah Lipton-Lubet…

Read More

Hair Straightener Lawsuits: Uterine Cancer Risks Highlight Need for Consumer Safety and Corporate Accountability

In recent years, many women have initiated lawsuits against hair product companies like Revlon and L’Oréal, an alarming trend worthy of legal and consumer attention. The root of these allegations lies mainly in the alleged side effects of chemical hair straighteners, especially considering the increased risk of developing uterine cancer. According to details from a…

Read More

Supreme Court Ruling Strengthens State Jurisdiction over Foreign Corporations in Product Liability Cases

In this analysis, we provide an update on the recent developments of product liability laws concerning major corporations and law firms primarily in Massachusetts but also including developments in New York and New Jersey. This coverage is based primarily on the ‘Product Liability Update – September 2023’ published by Foley Hoag LLP. In a significant…

Read More

Pharmaceutical Patent Dispute: Bristol-Myers Squibb and Xspray Pharma Locked in Sprycel/Dasynoc Legal Battle

In a recent development in the realm of patent law, Bristol-Myers Squibb Co. and Xspray Pharma AB are involved in a legal battle concerning the technology behind Sprycel®/Dasynoc® (dasatinib). The case, identified as Bristol-Myers Squibb Co. v. Xspray Pharma AB, No. CV 22-964 (RMB/MJS), 2023 WL 3354261 (D.N.J. Apr. 25, 2023) (Bumb, J.), pertains to…

Read More

Upholding HUD’s Disparate-Impact Rule: A Decisive Victory with Implications for Housing and Insurers

In a long-awaited decision, the U.S. District Court for the District of Columbia upheld the Department of Housing and Urban Development (HUD)’s Disparate-Impact Rule (Rule) last month. This marks the end of a decade-long string of legal challenges by insurance trade associations, arguing against the legality of the Rule under the Federal Housing Act (FHA)….

Read More

California Employers Face New Furlough Regulations: Ninth Circuit Ruling Implications

The state of California has recently found itself at the center of a crucial development in employment law concerning wage and hour regulations. In particular, attention has been drawn to the recent Ninth Circuit decision, which puts forth new requirements anchoring California employers that elect to furlough or temporarily lay off employees without providing them…

Read More

Analyzing Recent ERISA Litigation Decisions: Insights and Implications for Law Firms and Corporations

In the world of ERISA litigation, keeping an eye on recent decisions can be informative and potentially impactful for corporations and law firms alike. This October 2023 edition of The Friday Five, provides a concise exploration of recent rulings. Saul Ewing LLP highlights cases that cover a wide array of topics, including the questionable effect…

Read More

Assumption of Risk Doctrine: Insights from New York State Court of Appeals on High School Baseball Case

In a notable development, the New York State Court of Appeals recently provided new insights on a long-debated subject in the legal world: the assumption of risk doctrine. The case under consideration involved an injured high school baseball player, whose case, the court has affirmed, must proceed to trial. The assumption of risk doctrine, as…

Read More

PFAS Contamination Lawsuit to Proceed under Federal RICO Act: Setting a Precedent for Environmental Torts

In a notable legal turn of events, a federal magistrate judge has recommended that a lawsuit rooted in public drinking water contamination can proceed under the federal Racketeer Influenced and Corrupt Organizations (RICO) Act. The lawsuit stems from the use of per-and polyfluoroalkyl substances (PFAS), colloquially known as “forever chemicals,” by a paper mill near…

Read More

Private Equity Firms Beware: Bumble Bee Tuna Price-Fixing Case May Hold Legal Implications for Investors

The curious case of Bumble Bee Tuna, one of the long-running multidistrict litigations, took an unexpected turn. The corporate bigwigs mingling in private equity could learn more than a thing or two about the court’s recent decision. The cause: an alleged price-fixing conspiracy involving none other than a leading provider of seafood, canned tuna to…

Read More